Hydrofarm (HYFM) Insider Melisa Denis Buys 30,000 Shares

Melisa Denis, an insider at HYFM, purchased 30,000 shares on June 23, 2026. This transaction highlights ongoing insider interest in the company, which could be a point of focus for investors tracking insider activity.

Other Institutional Activity in HYFM

Renaissance Technologies LLC slightly trimmed its holdings by 300 shares, ending with 72,163 shares valued at about $73,606. Geode Capital Management, LLC, on the other hand, boosted its stake by 14,989 shares, reaching a total of 62,586 shares worth approximately $63,848, marking a 31.5% increase. BlackRock, Inc. and Prentice Capital Management, LP maintained their positions, holding 50,465 and 45,469 shares, respectively. Notably, Vanguard Capital Management LLC and Vanguard Fiduciary Trust Co both opened new positions, with the former acquiring 39,683 shares and the latter 18,082 shares.

Hydrofarm Holdings Group, Inc. Stock Down 11.5%

Shares of HYFM traded near $0.84 on Friday. The stock is part of a broader market movement, as it navigates its current trading range. Investors are likely keeping an eye on these price levels as they assess the company's future potential.

Insider Buying and Selling at Hydrofarm Holdings Group, Inc.

On June 23, 2026, multiple insiders, including Renah Persofsky, Patrick Chung, Richard Christopher Yetter, and Melisa Denis, each purchased 30,000 shares. These transactions were not part of any pre-planned trading programs. Earlier in the year, on January 6, 2026, CEO William Douglas Toler and CFO Kevin Patrick O'Brien sold 5,189 and 1,150 shares, respectively, at an average price of $1.51.

Analysts Set New Price Targets

Analysts have maintained a cautious stance on HYFM. On July 29, 2024, Stifel and Stifel Nicolaus both maintained their 'hold' ratings with a $0.75 price target. Truist Financial also retained a 'hold' rating with a target of $0.86 on March 1, 2024. These ratings suggest analysts are taking a conservative view of the company's prospects.

Bottom Line

Insider activity at HYFM, including Melisa Denis's recent purchase, is drawing attention. Institutional investors are also adjusting their positions, with some opening new stakes. While the stock trades at a low price point, analyst ratings suggest cautious optimism. As always, insider transactions are worth monitoring as part of a broader investment strategy, but they do not necessarily indicate future performance.